ARYX - ARYx Therapeutics, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
Total Revenue
0
Cost of Revenue
0
Gross Profit
0
Operating Expenses
Research Development
7,061
Selling General and Administrative
9,666
Total Operating Expenses
16,727
Operating Income or Loss
-16,727
Interest Expense
1,691
Total Other Income/Expenses Net
-
Income Before Tax
-
Income Tax Expense
-
Income from Continuing Operations
-18,328
Net Income
-18,328
Net Income available to common shareholders
-18,328
Reported EPS
Basic
-
Diluted
-
Weighted average shares outstanding
Basic
-
Diluted
-
EBITDA
-